This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1999 Apr;117(4):518-9.

doi: 10.1001/archopht.117.4.518.

Sildenafil (Viagra) and ophthalmology

PMID: 10206581
DOI: 10.1001/archopht.117.4.518

Review

Sildenafil (Viagra) and ophthalmology

M F Marmor. Arch Ophthalmol. 1999 Apr.

. 1999 Apr;117(4):518-9.

doi: 10.1001/archopht.117.4.518.

Author

PMID: 10206581
DOI: 10.1001/archopht.117.4.518

No abstract available

PubMed Disclaimer

Similar articles

Visual halos after sildenafil (Viagra).
Potter MJ, Behn D. Potter MJ, et al. Ophthalmology. 2002 May;109(5):823; author reply 823-4. doi: 10.1016/s0161-6420(02)01024-2. Ophthalmology. 2002. PMID: 11986069 No abstract available.
Sildenafil (Viagra) and ophthalmology.
Marmor MF, Kessler R. Marmor MF, et al. Surv Ophthalmol. 1999 Sep-Oct;44(2):153-62. doi: 10.1016/s0039-6257(99)00079-x. Surv Ophthalmol. 1999. PMID: 10541153 Review.
Viagra, sexual intercourse and acute myocardial infarction.
Dakik HA, Al-Sayyed A, Sawaya JI. Dakik HA, et al. Cardiology. 1999;92(3):220. doi: 10.1159/000006976. Cardiology. 1999. PMID: 10754356 No abstract available.
Comparison of reported and expected deaths in sildenafil (Viagra) users.
Wysowski DK, Farinas E, Swartz L. Wysowski DK, et al. Am J Cardiol. 2002 Jun 1;89(11):1331-4. doi: 10.1016/s0002-9149(02)02342-1. Am J Cardiol. 2002. PMID: 12031744 No abstract available.
Cyclic GMP phosphodiesterase-5: target of sildenafil.
Corbin JD, Francis SH. Corbin JD, et al. J Biol Chem. 1999 May 14;274(20):13729-32. doi: 10.1074/jbc.274.20.13729. J Biol Chem. 1999. PMID: 10318772 Review. No abstract available.

See all similar articles

Cited by

Sildenafil increases ocular perfusion.
Paris G, Sponsel WE, Sandoval SS, Elliott WR, Trigo Y, Sanford DK, Harison JM. Paris G, et al. Int Ophthalmol. 2001;23(4-6):355-8. doi: 10.1023/a:1014410932321. Int Ophthalmol. 2001. PMID: 11944862
Acquired color vision loss and a possible mechanism of ganglion cell death in glaucoma.
Nork TM. Nork TM. Trans Am Ophthalmol Soc. 2000;98:331-63. Trans Am Ophthalmol Soc. 2000. PMID: 11190032 Free PMC article.
Acute effects of sildenafil on Humphrey visual field and intraocular pressure.
Ermis SS, Inan UU, Samli M, Ozturk F. Ermis SS, et al. Int Ophthalmol. 2004 Mar;25(2):69-72. doi: 10.1023/b:inte.0000031735.45526.1c. Int Ophthalmol. 2004. PMID: 15290883
Drug-induced ocular disorders.
Li J, Tripathi RC, Tripathi BJ. Li J, et al. Drug Saf. 2008;31(2):127-41. doi: 10.2165/00002018-200831020-00003. Drug Saf. 2008. PMID: 18217789 Review.
Ocular toxicity assessment of chronic sildenafil therapy for pulmonary arterial hypertension.
Matieli L, Berezovsky A, Salomão SR, Allemann N, Martins EN, Hirai FE, Ota-Arakaki J, Morales MS, de Freitas D. Matieli L, et al. Graefes Arch Clin Exp Ophthalmol. 2016 Jun;254(6):1167-74. doi: 10.1007/s00417-016-3352-8. Epub 2016 Apr 19. Graefes Arch Clin Exp Ophthalmol. 2016. PMID: 27094700

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems